Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway
Natural Products and Bioprospecting · 2024-12 · 14 (1)
DOI: 10.1007/s13659-024-00446-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Natural Products and Bioprospecting, online erschienen am 24.04.2024. Verfasst von Bangrui Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, People's Republic of China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Province Clinical Research Center for Metabolic diseases, Scientific and Technological Innovation Team of Kunming Medical University, Union Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University.
Abstract (Originalsprache)
Breviscapine, a natural flavonoid mixture derived from the traditional Chinese herb Erigeron breviscapus (Vant.) Hand-Mazz, has demonstrated a promising potential in improving diabetic nephropathy (DN). However, the specific active constituent(s) responsible for its therapeutic effects and the underlying pharmacological mechanisms remain unclear. In this study, we aimed to investigate the impact of scutellarin, a constituent of breviscapine, on streptozotocin-induced diabetic nephropathy and elucidate its pharmacological mechanism(s). Our findings demonstrate that scutellarin effectively ameliorates various features of DN in vivo, including proteinuria, glomerular expansion, mesangial matrix accumulation, renal fibrosis, and podocyte injury. Mechanistically, scutellarin appears to exert its beneficial effects through modulation of the transforming growth factor-β1 (TGF-β1) signaling pathway, as well as its interaction with the extracellular signal-regulated kinase (Erk) and Wnt/β-catenin pathways. Graphical Abstract
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, People's Republic of China.
- Key Laboratory of Medicinal Chemistry for Natural Resource (Ministry of Education)Yunnan Provincial Center for Research and Development of Natural Products, School of Pharmacy, Yunnan University, Kunming, 650500, People…
- Department of Endocrinology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, People's Republic of China. shirourou325@sina.com.
Förderung
- Yunnan Province Clinical Research Center for Metabolic diseases
- Scientific and Technological Innovation Team of Kunming Medical University
- Union Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University
- Yunnan health training project of high level talents
Zitieren
APA
Huang, B., Han, R., Tan, H., Zhu, W., Li, Y., Jiang, F., Xie, C., Ren, Z., & Shi, R. (2024). Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway. Natural Products and Bioprospecting, 14(1). https://doi.org/10.1007/s13659-024-00446-y
Vancouver
Huang B, Han R, Tan H, Zhu W, Li Y, Jiang F, et al. Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway. Natural Products and Bioprospecting. 2024;14(1). doi:10.1007/s13659-024-00446-y
BibTeX
@article{Huang2024,
author = {Huang, Bangrui and Han, Rui and Tan, Hong and Zhu, Wenzhuo and Li, Yang and Jiang, Fakun and Xie, Chun and Ren, Zundan and Shi, Rou},
title = {Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway},
journal = {Natural Products and Bioprospecting},
year = {2024},
volume = {14},
number = {1},
doi = {10.1007/s13659-024-00446-y}
}
EUVIMED